| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.09▲ | 1.08▲ | 1.08▲ | 1.07▲ | 1.13▼ |
| MA10 | 1.10▲ | 1.11▼ | 1.11▼ | 1.11▼ | 1.15▼ |
| MA20 | 1.12▼ | 1.14▼ | 1.15▼ | 1.16▼ | 1.16▼ |
| MA50 | 1.16▼ | 1.17▼ | 1.18▼ | 1.14▼ | 1.18▼ |
| MA100 | 1.17▼ | 1.21▼ | 1.18▼ | 1.18▼ | 1.44▼ |
| MA200 | 1.19▼ | 1.18▼ | 1.15▼ | 1.16▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.007▼ | -0.007▼ | -0.014▼ | -0.004▼ |
| RSI | 41.937▼ | 38.782▼ | 38.823▼ | 42.412▼ | 43.755▼ |
| STOCH | 25.417 | 11.878▼ | 11.878▼ | 10.071▼ | 46.204 |
| WILL %R | -49.999 | -65.217 | -65.217 | -86.957▼ | -77.136▼ |
| CCI | -29.439 | -55.606 | -55.606 | -86.347 | -81.801 |
|
Monday, January 12, 2026 07:16 AM
(RTTNews) - AN2 Therapeutics Inc. (ANTX) announced that the U.S. FDA has cleared its investigator-initiated trial evaluating Epetraborole in 90 patients with Mycobacterium abscessus lung disease, ...
|
|
Friday, January 09, 2026 09:00 AM
Investors might want to bet on AN2 Therapeutics, Inc. (ANTX), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
|
|
Thursday, November 06, 2025 06:03 AM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/02/26 | 1.10 | 1.11 | 1.07 | 1.08 | 21,017 |
| 06/02/26 | 1.10 | 1.10 | 1.06 | 1.09 | 68,798 |
| 05/02/26 | 1.08 | 1.10 | 1.06 | 1.06 | 62,886 |
| 04/02/26 | 1.10 | 1.10 | 1.05 | 1.06 | 41,633 |
| 03/02/26 | 1.12 | 1.15 | 1.08 | 1.08 | 64,152 |
| 02/02/26 | 1.13 | 1.18 | 1.11 | 1.12 | 166,585 |
| 30/01/26 | 1.13 | 1.17 | 1.13 | 1.13 | 32,430 |
| 29/01/26 | 1.187 | 1.19 | 1.13 | 1.13 | 23,652 |
| 28/01/26 | 1.19 | 1.215 | 1.17 | 1.19 | 69,500 |
| 27/01/26 | 1.18 | 1.215 | 1.15 | 1.205 | 75,731 |
|
|
||||
|
|
||||
|
|